| Serial Number | 99027189 |
| Word Mark | ARIQOZY |
| Filing Date | Monday, February 3, 2025 |
| Status | 651 - SUSPENSION INQUIRY - MAILED |
| Status Date | Wednesday, May 6, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Translation of Words in Mark | The wording "ARIQOZY" has no meaning in a foreign language. |
| Goods and Services | Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, and auto-immune disease; Biotechnological preparations for medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, and auto-immune disease; Biological preparations for medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, and auto-immune disease; Medicines for medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, and auto-immune disease; Pharmaceuticals for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, and auto-immune disease |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, February 3, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | CMG Pharmaceutical CO., LTD. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Seoul 06112 KR |
| Event Date | Event Description |
| Monday, February 3, 2025 | NEW APPLICATION ENTERED |
| Monday, February 3, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, February 3, 2025 | APPLICATION FILING RECEIPT MAILED |
| Monday, July 14, 2025 | ASSIGNED TO EXAMINER |
| Friday, July 18, 2025 | NON-FINAL ACTION WRITTEN |
| Friday, July 18, 2025 | NON-FINAL ACTION E-MAILED |
| Friday, July 18, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, August 25, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, August 25, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, August 25, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, August 26, 2025 | SUSPENSION LETTER WRITTEN |
| Tuesday, August 26, 2025 | LETTER OF SUSPENSION E-MAILED |
| Tuesday, August 26, 2025 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Friday, May 1, 2026 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Wednesday, May 6, 2026 | SUSPENSION INQUIRY WRITTEN |
| Wednesday, May 6, 2026 | INQUIRY TO SUSPENSION E-MAILED |
| Wednesday, May 6, 2026 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |